GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (STU:1S70) » Definitions » Float Percentage Of Total Shares Outstanding

Cartesian Therapeutics (STU:1S70) Float Percentage Of Total Shares Outstanding : 11.34% (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cartesian Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cartesian Therapeutics's float shares is 2.02 Mil. Cartesian Therapeutics's total shares outstanding is 17.80 Mil. Cartesian Therapeutics's float percentage of total shares outstanding is 11.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cartesian Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cartesian Therapeutics's Institutional Ownership is 7.69%.

Cartesian Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cartesian Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.02/17.80
=11.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cartesian Therapeutics (STU:1S70) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (STU:1S70) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TCRX OCUL ATAI LCTX MCRB ENTA EYPT SCPH RENB XOMA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RNAC:USA 1S7:Germany
Address
65 Grove Street, Watertown, MA, USA, 02472
Website
https://www.selectabio.com
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Cartesian Therapeutics (STU:1S70) Headlines

No Headlines